Skip to content
stoqly
en

Popular

All languages

Figures come from SEC filings, which are in English. Company and industry names stay as filed.

$ USD

Popular

All currencies

Data is in US dollars, converted at the ECB reference rate of Oct 23, 2026.

Bioceres Crop Solutions Corp.

BIOX Nasdaq Agricultural Chemicals Financials FY2017–FY2025

Revenue Total sales reported in the income statement.
$335M
27.9% vs prior year
Operating margin Operating income as a share of revenue.
−0.7%
10.5 pts
Net income Profit after all expenses, interest and tax.
−$55.4M
1,396.1%
Free cash flow Cash from operations minus capital spending.
$44.3M
38.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−0.5%
7.2 pts
Market cap Last close times the latest diluted share count, so it is approximate.
—
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On −$3.78 EPS (TTM)

What Bioceres Crop Solutions Corp. does

No business description yet.

Legal name
Bioceres Crop Solutions Corp.
Fiscal year ends
June 30, 2025
Latest annual report
20-F · Nov 10, 2025
Accession · CIK
0001104659-25-108999
0001769484

Revenue and margins

Bioceres Crop Solutions Corp. had $335M of revenue in fiscal 2025, down 27.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $44.3M in fiscal 2025, 13.2% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Bioceres Crop Solutions Corp. returned $1.0M to shareholders in fiscal 2025, 2% of free cash flow. The diluted share count fell 0.4%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Bioceres Crop Solutions Corp. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $36.0M$33.5M$48.1M$44.5M$32.7M
Debt incl. finance leases $125M$145M$168M$179M$158M
Debt / equity 1.8x1.1x0.6x0.6x0.6x
Interest coverage 1.8x2.2x2.3x1.7x−0.1x
Current ratio 1.3x1.3x1.3x1.2x0.9x
Quick ratio 0.9x0.8x0.9x0.9x0.7x
Total assets $395M$518M$818M$853M$764M
Total liabilities $304M$360M$488M$501M$468M
Shareholders' equity $67.7M$127M$299M$315M$265M
Net debt (− = net cash) $88.7M$112M$120M$134M$125M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY17FY19FY20FY21FY22FY23FY24FY25
Net income is positive ✕ ✕ ✓ ✕ ✕ ✓ ✓ ✕
Cash from operations is positive ✕ ✓ ✓ ✕ ✕ ✓ ✓ ✓
Return on assets rose — — ✓ ✕ ✓ ✓ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓ ✓ ✕ ✕ ✓ ✓
Debt fell relative to assets — ✓ ✓ ✕ ✓ ✓ ✕ ✓
Current ratio rose — ✓ ✓ ✕ ✓ ✕ ✕ ✕
Share count didn't rise — — ✕ ✕ ✕ ✕ ✕ ✓
Gross margin rose — — ✓ ✕ ✕ ✓ ✕ ✕
Revenue rose relative to assets — — ✕ ✕ ✓ ✕ ✓ ✕
F-score — / 3— / 57 / 91 / 94 / 95 / 94 / 94 / 9
Accruals ratio —−21.9%−2.2%−0.2%2.3%2.4%−4.5%−13.0%
Altman Z'' ————————

9 years of figures

Amounts in USD. Hover a ratio’s name for its definition.

Download CSV
Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $41.2M — $161M $173M $210M $335M $420M $465M $335M
Gross profit $10.6M — $73.6M $79.5M $90.9M $126M $185M $187M $132M
Research and development $0.9M — $3.7M $4.2M $5.6M $6.9M $15.3M $17.2M $14.9M
Operating income $0.2M — $32.1M $39.1M $38.4M $39.9M $54.2M $45.9M −$2.2M
Interest expense $7.2M — $23.4M $20.9M $21.2M $17.9M $23.8M $26.9M $28.8M
Pretax income −$8.0M — −$9.4M $6.4M $10.5M $14.1M $19.1M $11.1M −$57.6M
Income tax −$1.9M — $7.0M $2.2M $14.4M $18.0M −$1.1M $3.8M $1.3M
Net income −$5.9M — −$18.4M $3.4M −$6.9M −$7.2M $18.8M $4.3M −$55.4M
Net income to common −$5.9M — −$18.4M $3.4M −$6.9M −$7.2M $18.8M $4.3M −$55.4M
Diluted EPS −$0.21 — −$0.60 $0.09 −$0.18 −$0.17 $0.30 $0.07 −$0.88
Diluted shares 0.03B — 0.03B 0.04B 0.04B 0.04B 0.06B 0.06B 0.06B
Cash flow
Cash from operations −$1.2M — $29.7M $9.3M −$6.2M −$17.5M $2.6M $41.7M $49.9M
Capital expenditure $0.6M — $2.0M $1.6M $2.8M $3.5M $11.4M $9.8M $5.6M
Free cash flow −$1.8M — $27.7M $7.7M −$9.0M −$21.0M −$8.8M $31.9M $44.3M
Stock-based compensation — — −$0.1M $3.4M $1.7M $1.4M $3.4M $14.1M $4.4M
Share buybacks — — — $0.0M $3.5M — $3.0M $0.7M $0.9M
Dividends paid $0.0M — — — — — $0.5M $0.2M $0.1M
Dividends and buybacks $0.0M — — $0.0M $3.5M — $3.4M $0.9M $1.0M
Balance sheet
Cash and short-term investments — $2.2M $3.5M $42.5M $36.0M $33.5M $48.1M $44.5M $32.7M
Total debt — $91.0M $104M $10.4M $125M $145M $168M $179M $158M
Current assets — $85.3M $98.2M $165M $211M $298M $397M $409M $308M
Current liabilities — $119M $116M $131M $168M $223M $299M $329M $338M
Inventory — $19.4M $27.3M $29.3M $61.0M $126M $140M $126M $87.6M
Property and equipment, net $46.4M $40.2M $43.8M $41.5M $48.0M $49.9M $67.9M $74.6M $74.6M
Goodwill — $14.4M $29.8M $25.5M $28.8M $36.1M $112M $112M $112M
Intangible assets $42.4M $26.7M $39.6M $35.3M $67.3M $76.7M $174M $177M $181M
Total assets — $197M $242M $298M $395M $518M $818M $853M $764M
Total liabilities — $164M $180M $237M $304M $360M $488M $501M $468M
Shareholders' equity $83.7M $13.7M $47.3M $46.2M $67.7M $127M $299M $315M $265M
Margins
Gross margin 25.7% — 45.9% 45.9% 43.4% 37.8% 43.9% 40.1% 39.3%
Operating margin 0.5% — 20.0% 22.6% 18.3% 11.9% 12.9% 9.9% −0.7%
Net margin −14.2% — −11.4% 1.9% −3.3% −2.2% 4.5% 0.9% −16.5%
FCF margin −4.4% — 17.2% 4.4% −4.3% −6.3% −2.1% 6.9% 13.2%
Returns
Return on capital — — 17.2% 183.1% 15.9% 10.8% 12.9% 6.7% −0.5%
Return on capital employed — — 25.5% 23.4% 16.9% 13.5% 10.4% 8.8% −0.5%
Return on equity −7.0% — −60.2% 7.2% −12.1% −7.4% 8.8% 1.4% −19.1%
Return on assets — — −8.4% 1.2% −2.0% −1.6% 2.8% 0.5% −6.9%
Return on tangible equity −14.2% — — — — −49.4% 148.5% 16.5% —
Growth
Revenue growth — — — 7.8% 21.0% 59.8% 25.4% 10.6% −27.9%
Net income growth — — — — −304.5% — — −77.2% −1,396.1%
EPS growth — — — — −290.0% — — −77.4% −1,402.2%
FCF growth — — — −72.3% −217.5% — — — 38.6%
Share count change — — — 19.5% 7.7% 7.9% 49.4% 0.5% −0.4%
Financial health
Debt / equity — 6.6x 2.2x 0.2x 1.8x 1.1x 0.6x 0.6x 0.6x
Interest coverage 0.0x — 1.4x 1.9x 1.8x 2.2x 2.3x 1.7x −0.1x
Current ratio — 0.7x 0.8x 1.3x 1.3x 1.3x 1.3x 1.2x 0.9x
Quick ratio — 0.6x 0.6x 1.0x 0.9x 0.8x 0.9x 0.9x 0.7x
Capital allocation
Capex / revenue 1.5% — 1.3% 1.0% 1.3% 1.0% 2.7% 2.1% 1.7%
Stock comp / revenue — — −0.1% 2.0% 0.8% 0.4% 0.8% 3.0% 1.3%
Payouts / FCF — — — 0.4% — — — 2.8% 2.3%
Quality scores
Piotroski F-score — — — 7.0 1.0 4.0 5.0 4.0 4.0
Accruals ratio — — −21.9% −2.2% −0.2% 2.3% 2.4% −4.5% −13.0%

Source: SEC EDGAR XBRL filings (CIK 0001769484). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open